What is Aurinia Pharmaceuticals's interest expense?

Aurinia Pharmaceuticals (AUPH) reported interest expense of $1.01M in Q1 2026.

How has Aurinia Pharmaceuticals's interest expense changed year-over-year?

Aurinia Pharmaceuticals's interest expense decreased by 5.2% year-over-year, from $1.07M to $1.01M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Aurinia Pharmaceuticals AUPH Interest Expense

Interest Expense at other companies

Rogers CorporationROG

$300K0.0%

Vera TherapeuticsVERA

$1.82M+1.7%

Agios PharmaceuticalsAGIO

$10.8M-32.9%

BridgeBio PharmaBBIO

$12.94M-28.6%

LQD

Liquidia CorporationLQDA

$6.49M+39.1%

Arrowhead ResearchARWR

$23.85M+10.2%

Segments

By geography

See full

Visp, Switzerland$1M-9.1%

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's interest expense?: Aurinia Pharmaceuticals (AUPH) reported interest expense of $1.01M in Q1 2026.
How has Aurinia Pharmaceuticals's interest expense changed year-over-year?: Aurinia Pharmaceuticals's interest expense decreased by 5.2% year-over-year, from $1.07M to $1.01M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.